Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Palbociclib After CDK and Endocrine Therapy (PACE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03147287
Recruitment Status : Recruiting
First Posted : May 10, 2017
Last Update Posted : February 7, 2019
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Erica Mayer, MD, MPH, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2020
  Estimated Study Completion Date : December 31, 2024